BTIG Research Assumes Thermo Fisher Scientific to Buy

Brokerage firm BTIG Research Assumes its rating on Thermo Fisher Scientific(NYSE:TMO). The shares have been rated Buy. The rating by BTIG Research was issued on Jul 22, 2016.

In a different note, On Jul 19, 2016, Barclays said it Maintains its rating on Thermo Fisher Scientific. In the research note, the firm Raises the price-target to $170.00 per share. The shares have been rated ‘Overweight’ by the firm. On Apr 29, 2016, Jefferies said it Downgrades its rating on Thermo Fisher Scientific. The shares have been rated ‘Hold’ by the firm.

Thermo Fisher Scientific (TMO) shares turned negative on Thursdays trading session with the shares closing down -0.08 points or -0.05% at a volume of 16,45,333. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $159.255. The peak price level was also seen at $159.255 while the days lowest was $156.56. Finally the shares closed at $158.82. The 52-week high of the shares is $159.5 while the 52-week low is $117.1. According to the latest information available, the market cap of the company is $62,498 M.

Thermo Fisher Scientific has also declared a cash dividend of $0.1500 on Jul 7, 2016. The shares will quote ex-dividend on Sep 13, 2016 and the record date has been fixed on Sep 15, 2016. The dividend payable date has been fixed on Oct 17, 2016.

Thermo Fisher Scientific(TMO) last announced its earnings results on Apr 28, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $4.29B. Analysts had an estimated revenue of $4.11B. Earnings per share were $1.80. Analysts had estimated an EPS of $1.74.

Several Insider Transactions has been reported to the SEC. On Jul 14, 2016, Thomas W Loewald (Senior Vice President) sold 8,025 shares at $155.00 per share price.Also, On Jul 7, 2016, Marc N Casper (Chief Executive Officer) sold 20,000 shares at $147.95 per share price.On Jun 16, 2016, Daniel P Shine (Senior Vice President) sold 6,900 shares at $148.34 per share price, according to the Form-4 filing with the securities and exchange commission.

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.